Managing ADHD Medications in Outpatient Settings: A Guide for Primary Care Providers

ADHD CME

Managing ADHD Medications in Outpatient Settings:
A Guide for Primary Care Providers

Overview

Anthony Rostain, MD discusses the ongoing management of ADHD medications as primary care providers and patients work together to find the most effective medication and dosage. There is a variety of medications to be considered, along with consideration of comorbidities. Dr. Rostain offers a clear evidence-based guide. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Discuss strategies for follow-up care of adults with ADHD
  • Monitor clinical outcomes and adverse effects
  • Titrate medications to achieve optimal improvement
  • Improve patient adherence
  • Address common misconceptions

Presented by

Anthony L. Rostain, MD, MA

Professor of Psychiatry and Pediatrics
University of Pennsylvania Perelman School of Medicine

Medical Director, Adult ADHD Treatment & Research Program
PENN Behavioral Health, University of Pennsylvania Health System
Philadelphia, Pennsylvania

Course Runs: Sept 1, 2020 – Sept 1, 2021

Cardiovascular Safety of ADHD Medication Treatments

ADHD CME

Cardiovascular Safety of ADHD Medication Treatments

Overview

In this session, Dr. Rostain discusses the considerations primary care practitioners should make when working with ADHD patients and stimulant medications. Cardiovascular safety should be assessed. If a patient has cardiovascular issues, Dr. Rostain lays out clearly the protocol to be followed. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Screen for cardiovascular risk before prescribing ADHD medications
  • Discuss with your patients the medication alternatives in treating ADHD
  • Monitor your patients safely when prescribing ADHD medications
  • Refer ADHD patients out to cardiology when cardiovascular risk is identified

Presented by

Anthony L. Rostain, MD, MA

Professor of Psychiatry and Pediatrics
University of Pennsylvania Perelman School of Medicine

Medical Director, Adult ADHD Treatment & Research Program
PENN Behavioral Health, University of Pennsylvania Health System
Philadelphia, Pennsylvania

Course Runs: Sept 1, 2020 – Sept 1, 2021

Best Practices for Treating and Monitoring ADHD

ADHD CME

Best Practices for Treating and Monitoring ADHD

Overview

In this webcast, Dr. Adler discusses best practices for treating and monitoring ADHD in adults. 

This webcast was recorded live and is being used with permission by the presenter.

Completing this course will help you:

  • List commonly used medications for adult ADHD
  • Begin treating an ADHD patient with proper dose of a chosen medication
  • Discuss with patients the Executive Function Deficits that accompany ADHD symptoms
  • Advise ADHD patients of the risk of diversion of medications
  • Discuss with patients the common side effects of ADHD medications and suggest work-arounds

PRESENTED BY

Lenard A. Adler, MD

Professor of Psychiatry and
Child and  Adolescent Psychiatry
Director Adult ADHD Program
NYU School of Medicine
New York, New York

Course Runs: Sept 1, 2020 – Sept 1, 2021

Making the Diagnosis and Optimizing Treatment Part 2 – Optimizing Treatment

ADHD CME

ADHD in Adults: Making the Diagnosis and Optimizing Treatment
Part 2: Optimizing Treatment

Overview

In this second of a two-part series on Diagnosing and Optimizing Treatment for ADHD, primary care clinicians will learn to choose and dose ADHD medications appropriately for symptom improvement, determine improvement levels through Measurement-Based Care, recognize side effects that would warrant medication change or adjustment, and refer patients appropriately for psycho-social support. Presented by a family physician who diagnoses and treats ADHD full-time, learners will walk away with a confidence in handling ADHD as we currently do anxiety, depression, and associated medications.

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Choose confidently between stimulant and non-stimulant medication for a particular patient
  • Titrate medication dosage up to an optimal level in each patient over an appropriate time period
  • Refer to a third party for adjunctive and appropriate psycho-social support
  • Follow and ADHD patient’s improvement with Measurement-Based Care
  • Identify adverse side effects of medication that would warrant a change to a different medication

Presented by

Oren Mason, MD

Principal, Attention MD

Assistant Professor
Michigan State University
College of Human Medicine
Grand Rapids, Michigan

Making the Diagnosis and Optimizing Treatment Part 1 – Making the Diagnosis

ADHD CME

ADHD in Adults: Making the Diagnosis and Optimizing Treatment
Part 1: Making the Diagnosis

Overview

In this first of a two-part series on Diagnosing and Optimizing Treatment for ADHD, primary care clinicians will learn the appropriate prompts for ADHD screening, how to make a complete ADHD diagnosis and how to schedule and monitor the prescription of medication for ADHD symptom relief. Presented by a family physician who diagnoses and treats ADHD full-time, learners will walk away with confidence in handling ADHD as we currently do anxiety, depression, and associated medications. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Make available the 6-question ASRS screener for your offie patients, and know what next steps to take when someone screens positive for ADHD
  • Use the ADH 18 symptom checklist and other prescribed methods for making a complete and thorough diagnosis of ADHD
  • Know what comorbid conditions patients might have that can trigger a screen for underlying ADHD
  • Prescribe medications for and ADHD trial treatment with confidence, and how to titrate those medications up to effective dosing.
  • Set up an effective patient visit schedule to diagnose, treat and monitor ADHD in patients. 

Presented by

Oren Mason, MD

Principal, Attention MD

Assistant Professor
Michigan State University
College of Human Medicine
Grand Rapids, Michigan

ADHD and Women Part 2 – Differences in Treatment

ADHD CME

Women and ADHD: Differences in Treatment

Overview

In this second of a two-part series on ADHD and Women, Ellen Littman, PhD discusses the unique situations of ADHD women with high IQs and those with hyperactive/impulsive presentation. The majority of the session focuses on the variety of successful therapeutic options for all women with ADHD.

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Successfully identify ADHD women with high IQs and hyperactive/impulsive type for diagnosis and care
  • Support ADHD women in the primary care setting to communicate directly and self-advocate for optimal medical care.
  • Recommend psychotherapeutic treatments and make referrals to qualified local professionals
  • Identify comorbid disorders that are common to ADHD women, and take steps to treat the disorder along with the underlying ADHD

Presented by

Ellen Littman, PhD

Clinical Therapist in Priivate Practice
Mt. Kisco, New York

Course Runs: Sept 1, 2020 – Sept 1, 2021

ADHD and Women Part 1 – Differences in Diagnosis

ADHD CME

Women and ADHD: Differences in Screening

Overview

In this first of a two-part series on ADHD and Women, Ellen Littman, PhD describes the significant difference in symptoms of ADHD in women vs. men. Because diagnostic criteria for ADHD were developed in the early 1900s based upon the symptoms of hyperactive boys, many young females and even older women have been missed in diagnosis. We now know what to look for in women with ADHD, and Part 1 provides that clarity for screening and diagnosis.

This webcast was recorded live and is being used with the permission of the presenter.

at the conclusion of this course you will be able to:

  • Interview women patients for chronic health complaints that can signal underlying ADHD
  • Differentiate ADHD symptoms to look for in female vs male patients
  •  Reduce misdiagnosis of anxiety and depression in women, and query further about underlying ADHD.
  • Recognize hormonal and emotional dysregulation cycles, isolated social life, and CNS hyper-sensitivities as potentials for ADHD screening. 

PRESENTED BY

Ellen Littman, PhD

Clinical Therapist in Private Practice
Mt. Kisco, New York

Course Runs: Sept 1, 2020 – Sept 1, 2021

Screening and Diagnosis of Adult ADHD in Primary Care

ADHD CME

Screening and Diagnosis of Adult ADHD

Overview

In this webcast, Dr. Mason describes the use of a screening tool to screen adult patients for ADHD; discusses making a complete diagnosis of adult ADHD in primary care; recommends initial medications and dosing to relieve symptoms; and discusses best practices for follow up with patients on a recurring basis to assess progress.

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Use a screener to screen adult patients for ADHD
  • Make a complete diagnosis of adult ADHD in primary care
  • Recommend initial medications and dosing to relieve symptoms
  • Follow up with patients on a recurring basis to assess progress

Presented by

Oren Mason, MD

Principal, Attention MD

Assistant Professor
Michigan State University
College of Human Medicine
Grand Rapids, Michigan

Course Runs: Sept 1, 2020 – Sept 1, 2021